These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 21392397)
21. DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin. Ciszewski WM; Tavecchio M; Dastych J; Curtin NJ Breast Cancer Res Treat; 2014 Jan; 143(1):47-55. PubMed ID: 24292814 [TBL] [Abstract][Full Text] [Related]
22. Activated forms of H-RAS and K-RAS differentially regulate membrane association of PI3K, PDK-1, and AKT and the effect of therapeutic kinase inhibitors on cell survival. Carón RW; Yacoub A; Li M; Zhu X; Mitchell C; Hong Y; Hawkins W; Sasazuki T; Shirasawa S; Kozikowski AP; Dennis PA; Hagan MP; Grant S; Dent P Mol Cancer Ther; 2005 Feb; 4(2):257-70. PubMed ID: 15713897 [TBL] [Abstract][Full Text] [Related]
23. Targeting epidermal growth factor receptor-associated signaling pathways in non-small cell lung cancer cells: implication in radiation response. Choi EJ; Ryu YK; Kim SY; Wu HG; Kim JS; Kim IH; Kim IA Mol Cancer Res; 2010 Jul; 8(7):1027-36. PubMed ID: 20587532 [TBL] [Abstract][Full Text] [Related]
24. Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways. Grana TM; Rusyn EV; Zhou H; Sartor CI; Cox AD Cancer Res; 2002 Jul; 62(14):4142-50. PubMed ID: 12124353 [TBL] [Abstract][Full Text] [Related]
25. Opposite effects of Ha-Ras and Ki-Ras on radiation-induced apoptosis via differential activation of PI3K/Akt and Rac/p38 mitogen-activated protein kinase signaling pathways. Choi JA; Park MT; Kang CM; Um HD; Bae S; Lee KH; Kim TH; Kim JH; Cho CK; Lee YS; Chung HY; Lee SJ Oncogene; 2004 Jan; 23(1):9-20. PubMed ID: 14712206 [TBL] [Abstract][Full Text] [Related]
26. H-RAS V12-induced radioresistance in HCT116 colon carcinoma cells is heregulin dependent. Carón RW; Yacoub A; Zhu X; Mitchell C; Han SI; Sasazuki T; Shirasawa S; Hagan MP; Grant S; Dent P Mol Cancer Ther; 2005 Feb; 4(2):243-55. PubMed ID: 15713896 [TBL] [Abstract][Full Text] [Related]
27. Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells. Steelman LS; Navolanic P; Chappell WH; Abrams SL; Wong EW; Martelli AM; Cocco L; Stivala F; Libra M; Nicoletti F; Drobot LB; Franklin RA; McCubrey JA Cell Cycle; 2011 Sep; 10(17):3003-15. PubMed ID: 21869603 [TBL] [Abstract][Full Text] [Related]
28. PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells. Aksamitiene E; Kholodenko BN; Kolch W; Hoek JB; Kiyatkin A Cell Signal; 2010 Sep; 22(9):1369-78. PubMed ID: 20471474 [TBL] [Abstract][Full Text] [Related]
29. Dual targeting of PI3K and MEK enhances the radiation response of K-RAS mutated non-small cell lung cancer. Toulany M; Iida M; Keinath S; Iyi FF; Mueck K; Fehrenbacher B; Mansour WY; Schaller M; Wheeler DL; Rodemann HP Oncotarget; 2016 Jul; 7(28):43746-43761. PubMed ID: 27248324 [TBL] [Abstract][Full Text] [Related]
30. Downstream effectors of oncogenic ras in multiple myeloma cells. Hu L; Shi Y; Hsu JH; Gera J; Van Ness B; Lichtenstein A Blood; 2003 Apr; 101(8):3126-35. PubMed ID: 12515720 [TBL] [Abstract][Full Text] [Related]
31. Impact of oncogenic driver mutations on feedback between the PI3K and MEK pathways in cancer cells. Yuen HF; Abramczyk O; Montgomery G; Chan KK; Huang YH; Sasazuki T; Shirasawa S; Gopesh S; Chan KW; Fennell D; Janne P; El-Tanani M; Murray JT Biosci Rep; 2012 Aug; 32(4):413-22. PubMed ID: 22668349 [TBL] [Abstract][Full Text] [Related]
32. YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells. Mantwill K; Naumann U; Seznec J; Girbinger V; Lage H; Surowiak P; Beier D; Mittelbronn M; Schlegel J; Holm PS J Transl Med; 2013 Sep; 11():216. PubMed ID: 24044901 [TBL] [Abstract][Full Text] [Related]
33. Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability. Law JH; Li Y; To K; Wang M; Astanehe A; Lambie K; Dhillon J; Jones SJ; Gleave ME; Eaves CJ; Dunn SE PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844753 [TBL] [Abstract][Full Text] [Related]
34. Function of erbB receptors and DNA-PKcs on phosphorylation of cytoplasmic and nuclear Akt at S473 induced by erbB1 ligand and ionizing radiation. Toulany M; Schickfluss TA; Fattah KR; Lee KJ; Chen BP; Fehrenbacher B; Schaller M; Chen DJ; Rodemann HP Radiother Oncol; 2011 Oct; 101(1):140-6. PubMed ID: 21723633 [TBL] [Abstract][Full Text] [Related]
35. Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells. Squires MS; Hudson EA; Howells L; Sale S; Houghton CE; Jones JL; Fox LH; Dickens M; Prigent SA; Manson MM Biochem Pharmacol; 2003 Feb; 65(3):361-76. PubMed ID: 12527329 [TBL] [Abstract][Full Text] [Related]
36. A common Chk1-dependent phenotype of DNA double-strand break suppression in two distinct radioresistant cancer types. Dinkelborg PH; Wang M; Gheorghiu L; Gurski JM; Hong TS; Benes CH; Juric D; Jimenez RB; Borgmann K; Willers H Breast Cancer Res Treat; 2019 Apr; 174(3):605-613. PubMed ID: 30607635 [TBL] [Abstract][Full Text] [Related]
37. Integrin α6/Akt/Erk signaling is essential for human breast cancer resistance to radiotherapy. Hu T; Zhou R; Zhao Y; Wu G Sci Rep; 2016 Sep; 6():33376. PubMed ID: 27624978 [TBL] [Abstract][Full Text] [Related]
38. Dual Targeting of Akt and mTORC1 Impairs Repair of DNA Double-Strand Breaks and Increases Radiation Sensitivity of Human Tumor Cells. Holler M; Grottke A; Mueck K; Manes J; Jücker M; Rodemann HP; Toulany M PLoS One; 2016; 11(5):e0154745. PubMed ID: 27137757 [TBL] [Abstract][Full Text] [Related]
39. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546 [TBL] [Abstract][Full Text] [Related]
40. Suppression of DNA-dependent protein kinase sensitize cells to radiation without affecting DSB repair. Gustafsson AS; Abramenkovs A; Stenerlöw B Mutat Res; 2014 Nov; 769():1-10. PubMed ID: 25771720 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]